BETOPTIC S
2,5MG/ML OPH GTT SUS 1X5ML
| SÚKL code | 0225141 |
|---|---|
| Name of the product | BETOPTIC S |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | BETOPTIC S |
| Supplement | 2,5MG/ML OPH GTT SUS 1X5ML |
| Strenght | 2,5MG/ML |
| Pharmaceutical form | Eye drops, suspension |
| Package | 1X5ML |
| Route | Ocular use |
| Language of the pack | Czech |
| Wrap type | Dropper container |
| Legal status | na lékařský předpis |
| Active substance | BETAXOLOL HYDROCHLORIDE (BETAXOLOLI HYDROCHLORIDUM) |
| ATC group | S01ED02 |
| ATC group name | BETAXOLOL |
| Doping | Beta-blokátory (zakázány pouze při soutěži v určitých sportech). Bližší informace viz www.antidoping.cz/cs/zakazane-leky |
Marketing authorisation information
| Registration Number | 64/1131/94-C |
|---|---|
| Type of MA | National |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 30. 04. 2023 |
| MA Holder | Novartis s.r.o., Praha |
| MA Holder country | ČESKÁ REPUBLIKA |
| Actual MA holder | Immedica Pharma AB, Stockholm |
| Actual MA holder country | ŠVÉDSKO |
cz